Literature DB >> 24827862

Second generation antipsychotics in adolescent anorexia nervosa: a new hypothesis of eligibility criteria.

Simone Pisano1, Gennaro Catone, Antonio Pascotto, Antonella Gritti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24827862     DOI： 10.1089/cap.2013.0124

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  3 in total

1.  Olanzapine-induced atypical neuroleptic malignant syndrome in an adolescent man with anorexia nervosa.

Authors:  Hasret Ayyıldız; Şenol Turan; Didem Gülcü; Cana Aksoy Poyraz; Esra Pehlivanoğlu; Fügen Çullu; Mehmet Kemal Arıkan
Journal:  Eat Weight Disord       Date:  2015-11-25       Impact factor: 4.652

Review 2.  Canadian practice guidelines for the treatment of children and adolescents with eating disorders.

Authors:  Jennifer Couturier; Leanna Isserlin; Mark Norris; Wendy Spettigue; Melissa Brouwers; Melissa Kimber; Gail McVey; Cheryl Webb; Sheri Findlay; Neera Bhatnagar; Natasha Snelgrove; Amanda Ritsma; Wendy Preskow; Catherine Miller; Jennifer Coelho; Ahmed Boachie; Cathleen Steinegger; Rachel Loewen; Techiya Loewen; Elizabeth Waite; Catherine Ford; Kerry Bourret; Joanne Gusella; Josie Geller; Adele LaFrance; Anick LeClerc; Jennifer Scarborough; Seena Grewal; Monique Jericho; Gina Dimitropoulos; David Pilon
Journal:  J Eat Disord       Date:  2020-02-01

Review 3.  Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatrists.

Authors:  Simone Pisano; Gennaro Catone; Stefania Veltri; Valentina Lanzara; Marco Pozzi; Emilio Clementi; Raffaella Iuliano; Maria Pia Riccio; Sonia Radice; Massimo Molteni; Annalisa Capuano; Antonella Gritti; Giangennaro Coppola; Annarita Milone; Carmela Bravaccio; Gabriele Masi
Journal:  Ital J Pediatr       Date:  2016-05-21       Impact factor: 2.638
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.